Clayton Medical Research Foundation Inc
501C3 Nonprofit Organization Information
Clayton Medical Research Foundation Inc is a 501(c)(3) charitable nonprofit in Carson City, Nevada (EIN 51-0306704). It has been tax-exempt since April 1988, and contributions to it are tax-deductible. Its Form 990 for tax year 2024 reports total revenue of $5,236,838 and net assets of $97,541,913. TaxExemptWorld has Form 990s on file for 15 tax years (2009–2024). It is one of 826 nonprofits in Carson City, NV.
Form 990 · Tax period ending Dec 2024 · Filed Nov 17, 2025 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): As a supporting organization to the Clayton Foundation for Research (Clayton) the Foundation's primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Clayton's other supporting entities.
The Tumor Targeting Toxins grant to the University of California, San Diego, funds research directed to the discovery and development of compounds for cancer therapy, compounds synthesized with proteins joined by a sortase reaction, and compounds with cancer stem cell and hormone targeting ligands coupled with toxins for delivery to ovarian tumors and other epithelial tumors. Patent applications have been filed for these technologies by Research Development Foundation (RDF), a tax-exempt supporting organization of the Foundation see (Schedule R, Part III), and collaborations have been and are…
The Novel Biologically Active Peptides and Small Proteins grant to the Salk Institute for Biological Studies funds research. The overreaching hypothesis of this project is that novel drug targets exist among the thousands of newly discovered microproteins. The list includes uncharacterized secreted bioactive peptides and small proteins. In the past two years the focus has shifted from intracellular microproteins to uncharacterized secreted bioactive peptides because they are similar to peptide hormones and neuropeptides, which have proven expellant drug targets. Consequently, this project has…
The MorfVeuss Discovery, Screening and Therapeutic Platform grant to the Salk Institute for Biological Studies funds research to develop a screening platform, called MorfVeuss, that will allow the discovery of micro-peptide drug targets while transforming these discoveries into gene and oncolytic viral therapeutic candidates. The objective of this platform is to overcome a critical unmet need in identifying and characterizing a novel class of therapeutics, building from very recent discoveries in the past decade in the emerging field of micro-proteins. Development of this platform should open…
Public charity (509(a)(3) supporting organization)
Prepared by TaxExemptWorld from IRS Form 990 e-file data (object ID 202533219349307813). Not an official IRS form.